Kim Margolin

15PUBLICATIONS
91CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 21, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Mar 27, 2026
CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Michael A Postow, Peter D Zang, Sumanta K Pal

|Aug 03, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.

Mohammed M Milhem, Yousef Zakharia, Diwakar Davar

|Jun 02, 2025
A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy.

Debarati Bhanja, Junjia Zhu, Hannah Wilding

|Jan 03, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.

Raymond Y Huang, Gilbert Youssef, Thomas Nelson

|Dec 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review.

Vivek Podder, Tulika Ranjan, Kim Margolin

Pageof 3

Frequent Collaborators

3 joint publications

Manmeet Singh Ahluwalia

2 joint publications

Michael B Atkins

2 joint publications

Philip O Scumpia

2 joint publications

Alexandra P Ikeguchi